Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Cash from Investing Activities (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Cash from Investing Activities for 4 consecutive years, with -$269.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 12.08% year-over-year to -$269.0 million, compared with a TTM value of -$1.0 billion through Dec 2025, down 14.55%, and an annual FY2025 reading of -$1.0 billion, down 14.55% over the prior year.
  • Cash from Investing Activities was -$269.0 million for Q4 2025 at GE HealthCare Technologies, down from -$148.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$84.0 million in Q2 2023 and bottomed at -$407.0 million in Q1 2025.
  • Average Cash from Investing Activities over 4 years is -$182.3 million, with a median of -$142.5 million recorded in 2024.
  • The sharpest move saw Cash from Investing Activities tumbled 315.48% in 2024, then skyrocketed 36.1% in 2025.
  • Year by year, Cash from Investing Activities stood at -$95.0 million in 2022, then rose by 7.37% to -$88.0 million in 2023, then crashed by 172.73% to -$240.0 million in 2024, then fell by 12.08% to -$269.0 million in 2025.
  • Business Quant data shows Cash from Investing Activities for GEHC at -$269.0 million in Q4 2025, -$148.0 million in Q3 2025, and -$223.0 million in Q2 2025.